Nassirpour R - Search Results

1

Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model.

Sun FX, Tohgo A, Bouvet M, Yagi S, Nassirpour R, Moossa AR, Hoffman RM. Sun FX, et al. Among authors: nassirpour r. Cancer Res. 2003 Jan 1;63(1):80-5. Cancer Res. 2003. PMID: 12517781

2

Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model.

Bouvet M, Wang J, Nardin SR, Nassirpour R, Yang M, Baranov E, Jiang P, Moossa AR, Hoffman RM. Bouvet M, et al. Among authors: nassirpour r. Cancer Res. 2002 Mar 1;62(5):1534-40. Cancer Res. 2002. PMID: 11888932

3

Bax-induction gene therapy of pancreatic cancer.

Pirocanac EC, Nassirpour R, Yang M, Wang J, Nardin SR, Gu J, Fang B, Moossa AR, Hoffman RM, Bouvet M. Pirocanac EC, et al. Among authors: nassirpour r. J Surg Res. 2002 Aug;106(2):346-51. doi: 10.1006/jsre.2002.6473. J Surg Res. 2002. PMID: 12175991

4

Nek6 mediates human cancer cell transformation and is a potential cancer therapeutic target.

Nassirpour R, Shao L, Flanagan P, Abrams T, Jallal B, Smeal T, Yin MJ. Nassirpour R, et al. Mol Cancer Res. 2010 May;8(5):717-28. doi: 10.1158/1541-7786.MCR-09-0291. Epub 2010 Apr 20. Mol Cancer Res. 2010. Retraction in: Mol Cancer Res. 2017 Mar;15(3):358. doi: 10.1158/1541-7786.MCR-16-0440 PMID: 20407017 Free article. Retracted.

5

miR-221 promotes tumorigenesis in human triple negative breast cancer cells.

Nassirpour R, Mehta PP, Baxi SM, Yin MJ. Nassirpour R, et al. PLoS One. 2013 Apr 24;8(4):e62170. doi: 10.1371/journal.pone.0062170. Print 2013. PLoS One. 2013. Retraction in: PLoS One. 2017 Apr 10;12(4):e0175869. doi: 10.1371/journal.pone.0175869 PMID: 23637992 Free PMC article. Retracted.

6

miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3.

Nassirpour R, Mehta PP, Yin MJ. Nassirpour R, et al. PLoS One. 2013 Nov 7;8(11):e79655. doi: 10.1371/journal.pone.0079655. eCollection 2013. PLoS One. 2013. Retraction in: PLoS One. 2017 Sep 8;12(9):e0184778. doi: 10.1371/journal.pone.0184778 PMID: 24244539 Free PMC article. Retracted.

7

Identification of tubular injury microRNA biomarkers in urine: comparison of next-generation sequencing and qPCR-based profiling platforms.

Nassirpour R, Mathur S, Gosink MM, Li Y, Shoieb AM, Wood J, O'Neil SP, Homer BL, Whiteley LO. Nassirpour R, et al. BMC Genomics. 2014 Jun 18;15(1):485. doi: 10.1186/1471-2164-15-485. BMC Genomics. 2014. PMID: 24942259 Free PMC article.

8

Urinary miRNA Biomarkers of Drug-Induced Kidney Injury and Their Site Specificity Within the Nephron.

Chorley BN, Ellinger-Ziegelbauer H, Tackett M, Simutis FJ, Harrill AH, McDuffie J, Atabakhsh E, Nassirpour R, Whiteley LO, Léonard JF, Carswell GK, Harpur E, Chen CL, Gautier JC. Chorley BN, et al. Among authors: nassirpour r. Toxicol Sci. 2021 Feb 26;180(1):1-16. doi: 10.1093/toxsci/kfaa181. Toxicol Sci. 2021. PMID: 33367795 Free PMC article.

9

Identification of Promising Urinary MicroRNA Biomarkers in Two Rat Models of Glomerular Injury.

Nassirpour R, Homer BL, Mathur S, Li Y, Li Z, Brown T, Carraher D, Warneke J, Bailey S, Percival K, O'Neil SP, Whiteley LO. Nassirpour R, et al. Toxicol Sci. 2015 Nov;148(1):35-47. doi: 10.1093/toxsci/kfv167. Epub 2015 Aug 7. Toxicol Sci. 2015. PMID: 26253709

10

Nephron segment specific microRNA biomarkers of pre-clinical drug-induced renal toxicity: Opportunities and challenges.

Nassirpour R, Ramaiah SK, Whiteley LO. Nassirpour R, et al. Toxicol Appl Pharmacol. 2016 Dec 1;312:34-41. doi: 10.1016/j.taap.2016.01.021. Epub 2016 Jan 29. Toxicol Appl Pharmacol. 2016. PMID: 26827821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters